• E Brocas, S Rolando, R Bronchard, F Fender, C Guérineau, and M Bruyère.
• Coordination des dons d'organes et de tissus, centre hospitalier Sud-Francilien, 91100 Corbeil-Essonnes, France. Electronic address: elsa.brocas@ch-sud-francilien.fr.
• Ann Fr Anesth Reanim. 2014 Dec 1;33(12):631-7.

ObjectiveBecause of graft shortages, an experimental programme of organ donation after Maastricht 3-type circulatory death (M3) has been proposed by the French organ procurement organization (Agence de la biomedicine: ABM). The aim of the study was to estimate how many potential patients were eligible for an M3-type organ donation, amongst deceased patients who have had life-support withdrawn.Patients And MethodsWe conducted a retrospective study looking at the notes of deceased patients in a French general intensive care unit (ICU), where organ donation is arranged in DBD donors.ResultsOver the year 2013, 1475 patients were admitted in ICU and 215 died. One hundred and one patients were brain-injured and 26 of them died following a decision to withdrawn life-support and without contraindication to organ donation. Among them, 2 patients (8%) met the criteria for the French M3-type organ donation protocol. A 12.5% increase in organ donation activity of our team and five organ transplantations could have been considered.ConclusionIf M3 organ donation is considered, a significant increase in transplantation would be expected.Copyright © 2014 Société française d’anesthésie et de réanimation (Sfar). Published by Elsevier SAS. All rights reserved.

22 keywords...

hide…